Skip to main content
Log in

Nocturia imposes economic burden in Germany, Sweden, UK

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2014/2015 euros

Reference

  • Weidlich D, et al. Annual direct and indirect costs attributable to nocturia in Germany, Sweden, and the UK. European Journal of Health Economics : 27 Sep 2016. Available from: URL: http://dx.doi.org/10.1007/s10198-016-0826-x

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nocturia imposes economic burden in Germany, Sweden, UK. PharmacoEcon Outcomes News 763, 26 (2016). https://doi.org/10.1007/s40274-016-3439-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-016-3439-9

Navigation